February 1, 2024 Comments Off on New patent for Pharmacyclics Llc drug IMBRUVICA Posted in: Patent Added Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Llc and is included in three NDAs. It is available from one supplier. There are forty-one patents…
The post New patent for Pharmacyclics Llc drug IMBRUVICA appea…
February 1, 2024 Comments Off on New patent for Abbvie drug RESTASIS MULTIDOSE Posted in: Patent Added Annual Drug Patent Expirations for RESTASIS+MULTIDOSE Restasis Multidose is a drug marketed by Abbvie and is included in one NDA. It is available from four suppliers. There are ten patents…
The post New patent for Abbvie drug RESTASIS MULTIDOSE appeare…
